Multiple non-ossifying fibromas as a cause of pathological femoral fracture in Jaffe-Campanacci syndrome

被引:14
作者
Cherix, Stephane [1 ]
Bilde, Yann [1 ]
Becce, Fabio [2 ]
Letovanec, Igor [3 ]
Ruediger, Hannes A. [1 ]
机构
[1] Univ Lausanne Hosp, Dept Orthopaed & Traumatol, CH-1011 Lausanne, Switzerland
[2] Univ Lausanne Hosp, Dept Diagnost & Intervent Radiol, CH-1011 Lausanne, Switzerland
[3] Univ Lausanne Hosp, Univ Inst Pathol, CH-1011 Lausanne, Switzerland
来源
BMC MUSCULOSKELETAL DISORDERS | 2014年 / 15卷
关键词
Jaffe-Campanacci syndrome; Multiple non-ossifying fibromas; Pathological fracture; Cafe-au-lait spots; Axillary freckles; Type; 1; neurofibromatosis;
D O I
10.1186/1471-2474-15-218
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Jaffe-Campanacci is a rare syndrome characterised by the association of cafe-au-lait spots, axillary freckles, multiple non-ossifying fibromas of the long bones and jaw, as well as some features of type 1 neurofibromatosis. There are less than 30 reported cases, and a genetic profile has not yet been determined. Furthermore, it has not been clarified whether it is a subtype of type 1 neurofibromatosis or a separate syndrome. The risk of pathological fracture is over 50%, due to substantial cortical thinning of the weight-bearing bones. Case presentation: A 17-year-old female patient, known for type 1 neurofibromatosis, presented with a low-energy distal femoral fracture due to disseminated large non-ossifying fibromas. Investigations revealed all of the distinctive signs of Jaffe-Campanacci syndrome. Both her distal femurs and proximal tibias exhibited multiple non-ossifying fibromas. The fracture was treated by open reduction and internal plate fixation. Some of the bony lesions were biopsied to confirm the diagnosis. The fracture healed eventless, as did the lesions biopsied or involved in the fracture. The other ones healed after curettage and bone grafting performed at the time of plate removal. Conclusion: Jaffe-Campanacci is a rare syndrome having unclear interactions with type 1 neurofibromatosis, which still needs to be characterised genetically. It is associated with a high risk of pathological fracture, due to the presence of multiple large non-ossifying fibromas of the long bones, with an expected normal healing time. Curettage and bone grafting promote healing of the lesions and should be considered to prevent pathological fracture. We agree with other authors that all patients with newly-diagnosed type 1 neurofibromatosis should undergo an osseous screening to detect disseminated non-ossifying fibromas, and evaluate the inherent risk of pathological fracture.
引用
收藏
页数:6
相关论文
共 16 条
  • [1] Al-Rikabi AC, 2005, SAUDI MED J, V26, P104
  • [2] Blaz M, 2011, POL J RADIOL, V76, P32
  • [3] MULTIPLE NON-OSSIFYING FIBROMATA WITH EXTRASKELETAL ANOMALIES - A NEW SYNDROME
    CAMPANACCI, M
    LAUS, M
    BORIANI, S
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1983, 65 (05): : 627 - 632
  • [4] Is Jaffe-Campanacci syndrome just a manifestation of neurofibromatosis type 1?
    Colby, RS
    Saul, RA
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2003, 123A (01) : 60 - 63
  • [5] Fletcher CDM, 2013, WHO classification of tumours of soft tissue and bone: WHO classification of tumours, V5
  • [6] Jaffe-Campanacci syndrome - A case report and review of the literature
    Hau, MA
    Fox, EJ
    Cates, JM
    Brigman, BE
    Mankin, HJ
    [J]. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (04) : 634 - 638
  • [7] HL J, 1958, TUMORS TUMOROUS COND
  • [8] Kotzot D, 1994, Clin Dysmorphol, V3, P328
  • [9] Kourelis Taxiarchis V, 2012, Conn Med, V76, P279
  • [10] MALLET JF, 1980, CHIR PEDIATR, V21, P179